LY-03012

N/A

Report date: 2025/07/22 20:00:10
NME

Base Information

Drug NameLY-03012
Drug Alias NameLY-03012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsDiabetes MellitusNeuralgiaDiabetic Neuropathies +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong Luye Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusNeuralgiaDiabetic Neuropathies +[5] 

Other Information

ATC CodeN/A
Related LinksN/A